Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees
Article
[키워드] adverse effect
Antenatal
BNT162b2 vaccine
Breastfeeding
COVID-19
COVID-19 vaccination
disease
dose
Efficacy
Evidence
expression
had no
human milk
IgA
IgA level
IgG
IgG antibody
IgG titer
Infant
Influenza
initial
lactating
mother
mRNA
mRNA vaccination
of BNT162b2
Outcomes research
produced
profile
Protective antibody
protective immunity
recommendation
reported
SARS-CoV-2-specific antibodies
SARS-CoV-2-specific antibody
secreted
significant increase
subsequent
Support
the vaccine
transfer
vaccination
Vaccine
vaccinee
viral infection
women
[DOI] 10.1038/s41541-021-00370-z PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41541-021-00370-z PMC 바로가기 [Article Type] Article